Fluid Sep Technologies specializes in membrane technologies that are increasingly valuable components in pharmaceutical production processes. Membrane separation technologies such as reverse osmosis, ultrafiltration, and microfiltration have long been utilized to concentrate and purify both small and large molecules. These membrane technologies have found various applications, covering a broad range of separation, concentration, and purification needs within the pharmaceutical industry.

We have specialization in the process such as like :

  • Erythromycin.
  • Cephalothin.
  • Sterptomycin.
  • Spectinomycin.
  • Lincomycin.
  • Vancomycin.
  • Kasugamysin.
  • Oxytetracycline.
  • L-lysin.
  • Glutamic.
  • Threonine.
  • L-Aspartame.
  • Glycin.
  • L-Arginine.
  • Phytase enzymes.
  • Protease.
  • L-lactic acid.
  • Citric.
  • Vc.
  • Vb12.
  • Vb2.
  •  Thymopetidum.

  •  Interferon.

  • Vaccine.

  • Puerarin.
  • Soybean peptide.
  • Nature color.
  • Tea polyphenol.

Nanofiltration or pervaporation can be employed to treat pharmaceutical waste streams, detoxifying them and reducing the volume of waste requiring incineration. In addition, membrane-based processes like liquid membranes or membrane-based multi-phase extractive enzymatic resolution enable the separation of enantiomeric and other isomeric mixtures. Nanofiltration or pervaporation can even enhance synthesis reaction conversion. Furthermore, high-performance tangential flow filtration proves instrumental in fractionating protein mixtures, integrating clarification and chromatographic processes for downstream processing of biomolecules.

Fluid Sep Technologies strives to provide a comprehensive perspective on these developments, showcasing their applications in laboratories, pilot plants, and commercial settings.